Masafumi Ono - Concepedia

Author

Masafumi Ono

Also Known As

Hideki Fujii, Hideyuki Hyogo, Kanji Yamaguchi, Kazuo Tsubota, M Ono, M. ONO, M. Ono, MASAFUMI ONO, Mai ONO, Masafumi ONO

227

Publications

7.9K

Citations

H-Index

120

Concepts

All Affiliations

Kochi Medical School Hospital Yokohama City University Hiroshima University Kurume University Saga University

About

Masafumi Ono is an author at Kochi Medical School Hospital specializing in medicine, pathology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.6K
2	Health Sciences	12	12	1.1K
3	Public Health	5	5	341
4	Business	1	1	22
5	Engineering	1	1	107

Masafumi Ono

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography Kento Imajo, Takaomi Kessoku, Yasushi Honda, Gastroenterology	2015	784
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, BMC Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisBody CompositionHepatology	2012	376
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Journal of Gastroenterology Metabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver Physiology	2015	326
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease Masato Yoneda, Shuhei Naka, Kazuhiko Nakano, BMC Gastroenterology	2012	278
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis Chikako Namikawa, Shuping Zhang, John Raynor Vyselaar, Journal of Hepatology	2004	234
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis Akira Hirose, Masafumi Ono, Toshiji Saibara, Hepatology	2007	230
Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient mice Yoshihisa Nemoto, Katsumi Toda, Masafumi Ono, Journal of Clinical Investigation	2000	228
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hepatology Research	2015	204
Pilot study of liraglutide effects in non‐alcoholic steatohepatitis and non‐alcoholic fatty liver disease with glucose intolerance in <scp>J</scp>apanese patients (<scp>LEAN</scp>‐<scp>J</scp>) Yuichiro Eguchi, Yoichiro Kitajima, Hideyuki Hyogo, Hepatology Research	2014	177
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD Hirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka, Hepatology Communications	2021	139

Page 1